Taken together, the expression of CBS, CD44, CHAC1, and SLC7A1 were positively associated with tumor progression, while HMOX1 and HMGCR were negatively associated with tumor progression, which was in line with the above study. This evidence concerns the gene CD44 and neoplasm.